IDEXX LABORATORIES INC (IX1.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock
612.6 EUR
+30.2 (+5.19%)
ChartMill assigns a Buy % Consensus number of 74% to IX1.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 501.57. This target is -18.13% below the current price.
IX1.DE was analyzed by 20 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about IX1.DE.
In the previous month the buy percentage consensus was at a similar level.
IX1.DE was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-13 | Credit Suisse | Maintains | Outperform |
| 2021-08-03 | Goldman Sachs | Maintains | Neutral |
| 2021-08-02 | Barclays | Maintains | Overweight |
| 2021-07-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-02-17 | Barclays | Initiate | Overweight |
IDEXX LABORATORIES INC / IX1.DE FAQ
What is the average price target for IDEXX LABORATORIES INC (IX1.DE) stock?
20 analysts have analysed IX1.DE and the average price target is 501.57 EUR. This implies a price decrease of -18.13% is expected in the next year compared to the current price of 612.6.
How do analysts rate IDEXX LABORATORIES INC (IX1.DE)?
The consensus rating for IDEXX LABORATORIES INC (IX1.DE) is 74 / 100 . This indicates that analysts generally have a positive outlook on the stock.